Researchers discover the adhesion mechanism of the bacterium that causes 40% of atypical pneumonias Blog Post

Researchers from Institute of Molecular Biology of Barcelona (IBMB-CSIC) –based in the Barcelona Science Park– and the Institute for Natural Science and Technology at the University of Osaka, has succeeded in determining the three-dimensional structure of proteins by means of which the bacteria Mycoplasma pneumoniae –that cause 40% of atypical pneumonias– attaches itself to human cells and initiates infection. From the structure, this team of scientists have designed antibodies that decrease this adhesion capacity and opens the door to develop new therapies and vaccines against this pathogen.

 

Ernest Giralt, first IRB Barcelona Emeritus Professor Blog Post

Ernest Giralt Lledó is retiring after 15 years at the Institute for Research in Biomedicine (IRB Barcelona), where he has played a key institutional and scientific role. Dr Giralt, today an international reference for science of excellence, will continue to be linked to Institute as an Emeritus Professor. This appointment will allow him to share his guidance and expertise with the current community of scientists.

 

The CNAG-CRG participates in a European project to improve medical assistance through interceptive medicine Blog Post

Scientists from the Centro Nacional de Análisis Genómico (CNAG-CRG), based in Barcelona Science Park and integrated to the Centre for Genomic Regulation (CRG) unites with hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united to revolutionize healthcare on the frame of LifeTime initiative. They are participating in two publications: a perspective article in the journal Nature and the LifeTime Strategic Research Agenda. They are now presenting how to improve leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.

 

IBEC and IRB Barcelona researchers receive funding from “La Caixa” for biomedical research Blog Post

Researchers from the Institute of Bioengineering of Catalonia (IBEC) and the Barcelona Institute for Biomedical Research (IRB) -based in the Barcelona Science Park- are part of the winning projects of the third Call for Applications Health Research Projects organized by “La Caixa ” Foundation, which this year allocates 18 million euros to 25 biomedical projects to tackle those diseases with the greatest global impact, such as cardiovascular, neurological, infectious and oncological.

Kumux launches a 2.0 software which creates differential light to improve human health and plant growth Blog Post

A spin-off by the University of Barcelona Enlighting Technologies, based in the Barcelona Science Park, has created Kumux to launch a 2.0 simulation spectrum software which, through patented algorithms, creates a differential light with beneficial effects for health for both people and plant growth. It is an smart lighting solution –autonomous and based on LED technology–, compatible with different systems and designed so that it can be integrated into any luminaire or control platform.

 

A global team involving ICUB-Tech researchers detects a type of unidentified astronomical object Blog Post

Researchers from the international collaborations LIGO and Virgo, in which the Institute of Cosmos Sciences of the UB (ICCUB) takes part under the coordination of Jordi Portell –co-director of the ICCUB Technology Unit, based in the Barcelona Science Park– have announced the discovery of an object of 2.6 solar masses, placing it firmly into so-called mass gap. That is an interval between the mass of the heaviest neutron star and the lightest blackhole, from which there were no observations yet.

 

IBEC researcher Pere Roca-Cusachs joins the European elite club in biology Blog Post

Pere Roca-Cusachs –group leader at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and associate professor at the Faculty of Medicine of the University of Barcelona (UB)– has been chosen to join the European Molecular Biology Organization (EMBO), a prestigious network that brings together some of the most brilliant researchers in the world.

 

Eugin presents pioneering advances in fertility and human reproduction at ESHRE 2020 Blog Post

An analysis of the environment in which the embryos that become implanted in the uterus develop reveals a lower number of senescent (aged) cells than those that are not successful. This is the result of a study presented yesterday at ESHRE 2020, which has been led by researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park. The group also submited at the congress another work –carried out with the Center for Genomic Regulation (CRG) and the collaboration of the National Center for Genomic Analysis (CNAG)– which reveals that the quality of the eggs can lie in the networks that create their genes.

 

Investment in companies in the field of life sciences and healthcare in Catalonia grew to €112M in 2019 Blog Post

Life sciences and healthcare start-ups and companies in Catalonia managed to attract €112M of investment in 2019, a figure that has remained stable for four years in a row and is 3% higher than in 2018, according to the study presented today by CataloniaBio & HealthTech and Biocat –based in the Barcelona Science Park– jointly with and EY. Investors and experts predict that in 2020 this will reach a record figure, boosted by an interest in the sector after Covid-19.